Gernot Marx

TL;DR: The follow-up data of those who have survived COVID-19-related acute respiratory distress syndrome (ARDS) is still very scarce as discussed by the authors, therefore, patients who have undergone invasive mechanical ventilation (IMV) were followed six months after discharge and Pulmonary function tests (PFTs), 6-min walk test (6MWT) and echocardiography were performed.

TL;DR: It is suggested that SLPI might be a post-operative biomarker of AKI after TAAA repair, with a superior diagnostic accuracy for patients without preexisting impaired renal function.

TL;DR: Clinical evidence that ruxolitinib treatment is feasible and can be beneficial in patients with COVID‐19 pneumonia, preventing cytokine storm and ARDS is provided.

TL;DR: The combination of pulse oximetry and capnometry offers the possibility to detect potentially life-threatening problems in ventilated patients during transport and may help to reduce the risk of transports.

TL;DR: In this paper, a prospective observational multinational study in twenty-four ICU centers in five countries was conducted to assess relationships between Dipeptidyl peptidase 3 (DPP3) during the initial ICU stay and short-term outcome in the AdrenOSS-1.